Phytochemical investigation of Fissistigma cupreonitens (Annonaceae) led to the isolation of 34 compounds. The chemical structures of all compounds were determined by spectroscopic methods. Among the isolates, compounds 20-27 and 31-34 were reported from this genus for the first time. From the results of the cytotoxicity assay against three human cancer cell lines (NCI-H226, NPC-TW01, and Jurkat E6-1), oxoaporphine compounds oxoxylopine (1), oxocrebanine (3), kuafumine (4) and lysicamine (5), and the flavonoid adunctin E (26) displayed significant cytotoxicity against NCI-H226 cell line, with IC 50 values of 8. 45, 8.10, 8.54, 12.83 and 12.00 μM, respectively, in comparison with the standard drug, cisplatin with IC 50 of 13.37 μM.
Air pollution contributes to the health impacts among the highly industrialization and mobilization societies. Epidemiological study demonstrated that fine particulate matter (PM) with a mean diameter less than 2.5 um (PM 2.5) has strong correlation with cancer malignancy [1] . PM2.5, classified as a human carcinogen (Group 1), has been identified as an important risk factor for all kinds of cancer including lung and nasopharynx cancers, and leukemia [1] [2] [3] [4] [5] .
Lung cancer remains one of the leading causes of cancer-related mortality around the world. Non-small cell lung cancer (NSCLC) is the most common lung cancer in humans, accounting for approximately 85% of lung cancer cases, and less is known regarding the specific mechanisms through which PM2.5 exposure promotes NSCLC growth and progression [6] [7] [8] [9] [10] [11] [12] . Unfortunately, many lung cancer cases show significant resistance to chemotherapeutic drugs [13] . Therefore, the development of new clinical drugs for lung cancer is an urgent matter [14] .
Natural phytochemicals from plants are attracting worldwide attention for their pharmacological effects in the prevention and treatment of cancers because of their low toxicity and potential biological activity [15, 16] . In previous studies, bioactive natural products inhibited the initiation, promotion, and progression of carcinogenesis in human cancer cells and were developed as promising chemotherapeutic agents against cancers [17, 18] . Among the most promising anticancer candidates are alkaloids [19] . Certain plants families such as Annonaceae proved to be a rich source of cytotoxic alkaloids [20, 21] .
The genus Fissistigma (Annonaceae), comprises 100 species, is widely distributed in Africa, Asia, and Oceania. The phytochemical content of certain species of this genus were investigated such as F. maclurei [22] , F. poilanei [23] , F. latifolium [24] , F. bracteolatum [25] , F. cavaleriei [26] , F. petelotii [27] , F. oldhamii [28] , F. acuminatissima [29] , F. pallens [30] , F. capitatum [29] , F. rubiginosum [30] , F. glaucescens [31] , F. balansae [32] , F. polyanthoides [33] , F. polyanthum [34] , F. kwangsiense [35] , F. chloroneurum [29] and F. lanuginosum [36] . Alkaloids, flavonoids, triterpenoids, furanones, cyclopentenones, and benzenoids were reported from this genus [28, 29, 37, 38] . Bioactive components such as alkaloids and flavonoids showed cytotoxic, anti-inflammatory, antiplatelet aggregation, and immunosuppressive activities [39, 40] . In this work, we present the separation and identification of bioactive components from F. cupreonitens. Despite the extensive studies on other Fissistigma species, few previous phytochemical and biologically active studies were performed on F. cupreonitens [41] .
The present work reports the isolation and identification of 17 alkaloids, including seven oxoaporphines, oxoxylopine (1) [28] , oxoisocalycinine (2) [42] , oxocrebanine (3) [31] , kuafumine (4) [31] , lysicamine (5) [42] , noraristolodione (6) [28] , and norcepharadione B (7) [28] , eight aristolactams, aristolactam AII (8) [28] , aristolactam AIIIa (9) [28] , aristolactam FII (10) [28] , goniothalactam (11) [28] , piperlactam A (12) [28] , piperlactam C (13) [40] , isostigmalactam (14) [28] , and aristolactam AIa (15) [43] , two amides, N-trans-feruloyltyramine (16) [44] and N-cisferuloyltyramine (17) [44] . Ten flavonoids 18-27 were also isolated including two flavanones, pinostrobin (18) [48] , and orientin (22) [49] , and five dihydrochalcones, 2',6'-dihydroxy-3',4'-dimethoxydihydrochalcone (23) [50] , 2',6'-dihydroxy-4'-methoxydihydrochalcone (24) [51] , piperaduncin C (25) [51] , adunctin E (26) [52] , and hostmanin C (27) [53] , along with one triterpenoid taraxerol (28) [29] , four benzenoids, syringic acid (29) [54] , vanillic acid (30) [24] , methyl ferulate (31) [55] , and methyl-p-coumarate (32) [55] , one ionone boscialin (33) [56] , and one sesquiterpenoid abscisic acid (34) [57] . Among all isolates, 20-27 and 31-34 were obtained from genus Cisplatin, the platinum-based drug, is one of the most used drugs in the clinical treatment for a wide variety of tumors, including nonsmall cell lung cancer (NSCLC). However, the acquired resistance to cisplatin has led to clinical failures in cancer therapy [58] . Therefore, it is essential to develop new therapeutic entities to be included in the arsenal of drugs fighting this disease. The in vitro cytotoxic activity of the isolates was evaluated against human non-small cell lung carcinoma (NCI-H226), nasopharyngeal carcinoma (NPC-TW01), and T cell leukemia (Jurkat E6-1) cell lines. As shown in Table 1 , the results showed that oxoaporphine derivatives 1, 3, 4 and 5, and the flavonoid 26 displayed more potent cytotoxicity against NCI-H226 cell line than that of the positive control, cisplatin (IC 50 Fraction 3 (6.80 g) was purified by chromatography on a silica gel column (16 × 8 cm, CHCl 3 →MeOH, gradient) to yield seven subfractions. The subfraction 3-1 (377.8 mg) was further purified by preparative thin layer chromatography with n-hexane-EtOAc (8:1) to afford adunctin E 26 (6.9 mg). The subfraction 3-2 (504.6 mg) was purified by preparative thin layer chromatography (CHCl 3 ) to afford taraxerol 28 (5.8 mg). The subfraction 3-3 (5.0 g) was purified by chromatography on a silica gel column (14 × 3 cm, n-hexane:EtOAc, 30:1) to afford hostmanin C 27 (4.5 mg). The subfraction 3-6 (260.0 mg) was purified by preparative thin layer chromatography to afford lysicamine 5 (2.1 mg) and norcepharadione B 7 (5.7 mg).
Fraction 4 (9.6 g) was purified (22 × 4.5 cm, Sephadex LH-20, MeOH eluent) to afford seven subfractions. The subfraction 4-2 (5.0 g) was further purified by repeated chromatography to obtain oxocrebanine 3 (6.0 mg), kuafumine 4 (2.9 mg), vanillic acid 30 (11.0 mg), syringic acid 29 (1.9 mg), boscialin 33 (5.8 mg), and noraristolodione 6 (2.6 mg).
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Natural Product Communications Vol. 13 (6) 3 mg) and N-cis-feruloyltyramine 17 (3.7 mg). Fraction 6 (3.0 g) was isolated by chromatography on a silica gel column (11 × 5.5 cm, CHCl 3 →MeOH, gradient) to yield nine subfractions. The subfraction 6-2 (49.3 mg) was purified by reversed-phase preparative thin layer chromatography with MeOH-H 2 O (8:2) to afford oxoisocalycinine 2 (1.9 mg) and oxoxylopine 1 (2.3 mg), and the subfraction 6-5 (201.9 mg) was purified by preparative thin layer chromatography with CHCl 3 -MeOH (30:1) to afford aristolactam AIa 15 (2.1 mg) and aristolactam AIIIa 9 (2.5 mg).
Fraction 7 (7.1 g) was isolated by chromatography on a silica gel column (11 × 5.5 cm, CHCl 3 →MeOH, gradient) to yield seven subfractions. The subfraction 7-5 (1.8 g) was further purified by reversed-phase preparative thin layer chromatography (MeOH:H 2 O, 3:7) to afford isovitexin 20 (3.2 mg), and the subfraction 7-6 (1.7 g) was further purified by repeated chromatography to afford orientin 22 (3.5 mg) and isoorientin 21 (5.2 mg).
Cytotoxicity Assay: The isolated compounds from Fissistigma cupreonitens were screened for in vitro growth inhibitory activity against human non-small cell lung carcinoma (NCI-H226), nasopharyngeal carcinoma (NPC-TW01), and T cell leukemia (Jurkat E6-1) cell lines using the MTT assay as previously described [59] 
